{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:08:12Z","timestamp":1793142492010,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2024J408"],"award-info":[{"award-number":["2024J408"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007834","name":"Natural Science Foundation of Ningbo Municipality","doi-asserted-by":"publisher","award":["2022J021"],"award-info":[{"award-number":["2022J021"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.prp.2025.156089","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:51:50Z","timestamp":1750254710000},"page":"156089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Clinicopathological significance of identifying glypican 3 -positive gastric cancer"],"prefix":"10.1016","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-3155","authenticated-orcid":false,"given":"Hai-fen","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-hua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.prp.2025.156089_bib1","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/15384101.2020.1731945","article-title":"Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA [J]","volume":"19","author":"Wei","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.prp.2025.156089_bib2","article-title":"Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma","volume":"12","author":"Zheng","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.prp.2025.156089_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mco.2024.2796","article-title":"Evaluation of glypican-3 in patients with hepatocellular carcinoma","volume":"22","author":"Batbaatar","year":"2024","journal-title":"Mol. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.prp.2025.156089_bib4","first-page":"435","article-title":"[A bioinformatics analysis of differentially expressed genes associated with liver cancer]","volume":"25","author":"Bai","year":"2017","journal-title":"Zhonghua Gan Zang Bing. Za Zhi"},{"issue":"15","key":"10.1016\/j.prp.2025.156089_bib5","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1158\/1078-0432.CCR-19-3259","article-title":"Chimeric antigen receptor-glypican-3 T-cell therapy for advanced hepatocellular carcinoma: results of phase I trials [J]","volume":"26","author":"Shi","year":"2020","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.156089_bib6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fonc.2019.00248","article-title":"Next-generation cancer immunotherapy targeting glypican-3","volume":"9","author":"Shimizu","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.156089_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2021.100391","article-title":"Identification of GPC3 mutation and up-regulation in a multidrug resistant osteosarcoma and its spheroids as therapeutic target","volume":"30","author":"Nie","year":"2021","journal-title":"J. Bone Oncol."},{"issue":"4","key":"10.1016\/j.prp.2025.156089_bib8","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1349-7006.2009.01108.x","article-title":"Glypican 3-expressing gastric carcinoma: distinct subgroup unifying hepatoid, clear-cell, and alpha-fetoprotein-producing gastric carcinomas [J]","volume":"100","author":"Ushiku","year":"2009","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.prp.2025.156089_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/med.21455","article-title":"Glypican-3: a promising biomarker for hepatocellular carcinoma diagnosis and treatment [J]","volume":"38","author":"ZHOU","year":"2018","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.prp.2025.156089_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2024.114391","article-title":"GPC-3 in hepatocellular carcinoma; a novel biomarker and molecular target","volume":"444","author":"Tehrani","year":"2025","journal-title":"Exp. Cell Res"},{"issue":"6","key":"10.1016\/j.prp.2025.156089_bib11","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1309\/HCQWPWD50XHD2DW6","article-title":"Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples","volume":"129","author":"Baumhoer","year":"2008","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2025.156089_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2018.04.022","article-title":"Next-generation sequencing analysis for gastric adenocarcinoma with enteroblastic differentiation: emphasis on the relationship with hepatoid adenocarcinoma","volume":"78","author":"Akazawa","year":"2018","journal-title":"Hum. Pathol."},{"issue":"10","key":"10.1016\/j.prp.2025.156089_bib13","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.prp.2018.07.037","volume":"214","author":"Zhao","year":"2018","journal-title":"Pathol. Res Pr."},{"issue":"1","key":"10.1016\/j.prp.2025.156089_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/s12876-021-01986-0","article-title":"Both the serum AFP test and AFP\/GPC3\/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Gastroenterol."},{"issue":"5","key":"10.1016\/j.prp.2025.156089_bib15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2559.2006.02522.x","article-title":"Hepatocellular oncofetal protein, glypican 3 is a sensitive marker for alpha-fetoprotein-producing gastric carcinoma","volume":"49","author":"Hishinuma","year":"2006","journal-title":"Histopathology"},{"issue":"28","key":"10.1016\/j.prp.2025.156089_bib16","doi-asserted-by":"crossref","first-page":"44406","DOI":"10.18632\/oncotarget.9763","article-title":"Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer [J]","volume":"7","author":"HAN","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2025.156089_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1267186","article-title":"Comprehensive multi-omics analysis of tryptophan metabolism-related gene expression signature to predict prognosis in gastric cancer","volume":"14","author":"Luo","year":"2023","journal-title":"Front Pharm."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825002821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:39:07Z","timestamp":1777559947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825002821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":17,"alternative-id":["S0344033825002821"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156089","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological significance of identifying glypican 3 -positive gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"156089"}}